|Last Update: 05/21/13 - 4:00 PM EDT|
|YTD Performance: 26.56%|
|Previous Close: $54.82|
|52 Week Range: $35.98 - $56.91|
|Oustanding Shares: 230,907,431|
|Market Cap: 12,658,345,367|
|Qtr (06/13)||Qtr (09/13)||FY (09/13)||FY (09/14)|
|Number of Analysts||8||7||1||9|
|Growth Rate (Year over Year)||4.17%||6.00%||7.42%||20.10%|
ABC was downgraded from Outperform to Neutral, Robert Baird said. Valuation call, based on a $57 price target.
ABC was upgraded to Buy, Goldman Sachs said. New deal will WAG creates a sustainable competitive advantage. $61 price target.
ABC estimates were raised through 2014, Lazard Capital Markets said. Walgreen relationship and buybacks can drive profit upside. Buy rating and new $60 price target.
ABC was upgraded to Buy from Neutral, said Citigroup. The deal with Walgreens will be transformational, increasing international reach and adding purchasing power. Price target is $62.
ABC was downgraded from Buy to Neutral, ISI Group said. Valuation call, based on a $54 price target.
Shares of ABC were downgraded to Neutral, said UBS. The company's premium valuation is less warranted given specialty distribution will be less likely to drive superior EPS growth vs. peers.
ABC was downgraded from Strong Buy to Buy, ISI Group said. $53 price target. Valuation call, as the stock is up 23% since October.
Safety stocks aren’t every going to be crushed, but could certainly stumble.
AmerisourceBergen Annual Shareholder Meeting - 2PM
ABC was downgraded from Buy to Netural, Robert Baird said. Valuation call, based on a $45 price target.